| 标题 |
Cost-effectiveness analysis of dabigatran versus rivaroxaban for stroke prevention in patients with non-valvular atrial fibrillation using real-world evidence in elderly US Medicare beneficiaries |
| 网址 | |
| DOI | |
| 其它 | Peng S, Deger KA, Ustyugova A, Gandhi P, Qiao N, Wang C, Kansal AR. Cost-effectiveness analysis of dabigatran versus rivaroxaban for stroke prevention in patients with non-valvular atrial fibrillation using real-world evidence in elderly US Medicare beneficiaries. Curr Med Res Opin. 2018 Jan;34(1):55-63. doi: 10.1080/03007995.2017.1375470. Epub 2017 Sep 26. PMID: 28862479. |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)